At Legally Pink Law, we’re your Orlando product liability attorneys
for information regarding drug safety and recall notices. The US Food
and Drug Administration (FDA) is currently weighing whether the non steroidal
anti-inflammatory drugs (NSAIDs) including Celebrex and Naproxen should
come with warnings for increased risk of cardiac events. The FDA is postponing
decisions until a study is complete.
The study of 95,000 patients is currently underway and will be complete
in late 2015. The 7-year study will answer long-standing questions about
the safety of NSAIDs and potential risk for cardiac events. In 2005, the
FDA determined that NSAIDs
should list warnings of cardiac event risk, but the FDA didn’t have enough
evidence to enforce the policy.
If you believe you or a loved one have suffered a cardiac event as the
result of medical negligence or product defect, call us at
Legally Pink Law today for representation. We’ll work to ensure that your medical
malpractice or negligence case is handled with rigor in order to help
you earn the highest compensation for medical expenses, pain, and suffering.